Featuring perspectives from Dr Mitesh J Borad and Dr Amit Mahipal, including the following topics:

• Introduction (0:00)
• Targeted Therapeutic Approaches for Patients with Biliary Tract Cancers (BTCs) — Dr Mahipal (4:59)
• Integration of Immune Checkpoint Inhibitors into Current BTC Management — Dr Borad (32:16)

CME information and select publications

Featuring perspectives from Ms Marianne J Davies, Dr Edward B Garon, Ms Marissa Marti-Smith and Dr Tiffany A Traina, including the following topics:

• Introduction (0:00)
• Overview of Antibody-Drug Conjugates (ADCs) (4:40)
• Trastuzumab Deruxtecan (T-DXd) in Patients with HER2-Positive Metastatic Breast Cancer (mBC) with and without Brain Metastases (12:40)
• Role of ADCs for Patients with ER-Positive mBC (35:09)
• T-DXd in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) with HER2 Alterations (52:20)
• Emerging Role of ADCs for Patients with Progressive EGFR-Mutant NSCLC (1:12:20)

NCPD information and select publications

Featuring an interview with Dr Adam M Brufsky, including the following topics:

• Case: A woman in her early 50s with ER-positive, HER2-low de novo metastatic breast cancer (0:00)
• Case: A woman in her late 70s with ER-positive, HER2-low metastatic breast cancer after 5 years of an adjuvant aromatase inhibitor (6:52)
• Clinical Investigator Survey Results (10:05)

CME information and select publications